Business ❯ Corporate Governance ❯ Investor Relations ❯ Public Companies

Stock Performance

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Investors face a May 5 deadline to seek lead‑plaintiff status in a case claiming the company hid safety risks tied to VYKAT XR.

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case